L’Oréal, the French multinational beauty conglomerate, has agreed to acquire a controlling interest in Medik8, a UK-based skincare brand renowned for its science-driven, dermatologically focused products. The acquisition, announced on Monday, marks a significant step in L’Oréal’s strategy to solidify its footprint in the premium dermocosmetic segment, a market that continues to experience rapid global growth.